< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 82
- Developing broad-spectrum antiviral drugs for pandemic preparednessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- New AntiVirals for Infections with Pandemic PotentialFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- European Viral Outbreak Response AllianceFrom1 Jan 2024 → TodayFunding: HORIZON.1.3 - Research Infrastructures
- Classic and new strategies to fight alphavirusesFrom18 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Towards strategies for the treatment and prevention of henipavirus infections.From21 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
Publications
491 - 500 of 621
- Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase(2012)
Authors: Leen Delang, Mathy Froeyen, Piet Herdewyn, Johan Neyts
Pages: 30 - 38 - Antiviral activity of Bay 41-4109 on Hepatitis B Virus in humanized Alb-uPA/SCID mice(2011)
Authors: Johan Neyts
- Conformationally locked nucleoside analogues based on the bridgehead substituted 7-oxonorbornane and their antiviral properties(2011)
Authors: Johan Neyts, Pieter Leyssen
Pages: 1549 - 1566 - Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action(2011)
Authors: Jan Paeshuyse, Kai Dallmeier, Johan Neyts
Pages: 590 - 598 - The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication(2011)
Authors: Johan Neyts
Pages: 271 - 276 - Crucial role of the N-glycans on the E-envelope glycoprotein of DC-SIGN mediated dengue virus infection(2011)
Authors: Marijke Alen, Kai Dallmeier, Jan Balzarini, Johan Neyts, Dominique Schols
Pages: 280 - 287 - SYNERGY OF ENTRY INHIBITORS AND DIRECT ACTING ANTIVIRALS OR INTERFERON-ALFA IDENTIFIES NOVEL ANTIVIRAL COMBINATIONS FOR HEPATITIS C VIRUS INFECTION(2011)
Authors: Isabel Fofana, Fei Xiao, Christine Thumann, Joachim Lupberger, Pieter Leyssen, Johan Neyts, Francois Habersetzer, Michel Doffoel, Miriam B Zeisel, Thomas F Baumert
Pages: 401A - 401A - Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication(2011)
Authors: Johan Neyts, Jan Balzarini
Pages: 4281 - 4288 - Comparative Study of the Genetic Barriers and Pathways towards Resistance of Selective Inhibitors of Hepatitis C Virus Replication(2011)
Authors: Leen Delang, Inge Vliegen, Mathy Froeyen, Johan Neyts
Pages: 4103 - 4113 - Mechanistic characterization of GS-9190 (Tegobuvir), a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase(2011)
Authors: Inge Vliegen, Jan Paeshuyse, Johan Neyts
Pages: 4196 - 4203
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)